Atlas Trials

IDEAYA Biosciences

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch IDEAYA Biosciences

RecordFirmDate
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors (NCT07540572)IDEAYA Biosciences2026-03-17
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors (NCT07277413)IDEAYA Biosciences2026-03-04
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types (NCT07503808)IDEAYA Biosciences2026-02-24
Neoadjuvant Darovasertib in Primary Uveal Melanoma (NCT07015190)IDEAYA Biosciences2026-01-25
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer (NCT07174583)IDEAYA Biosciences2025-10-14
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma (NCT05987332)IDEAYA Biosciences2023-10-31
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma (NCT05907954)IDEAYA Biosciences2023-07-03
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors (NCT05787587)IDEAYA Biosciences2023-04-18
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion (NCT04794699)IDEAYA Biosciences2021-04-14
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions (NCT03947385)IDEAYA Biosciences2019-06-28

Track IDEAYA Biosciences automatically

Every clearance here is in the API, with alerts when new ones post.